EHTH

eHealth's income statement is finally healing: FY2025 revenue of $554M (+4.1%) came with $66.5M operating income (+182%) and $40.0M net income, capping a four-year swing from a -$104M loss in FY2021 to black ink. MD&A explains the driver — back-to-back years of Medicare Advantage disruption, where carriers pulled unprofitable plans and hiked commission rates, pushed elevated consumer demand into eHealth's marketplace while its AI screener and shift to owned branded channels cut acquisition cost. On the surface a $49.7M market cap against $554M of sales, $592M of equity and $66.5M of operating income looks like a screaming value.

The reason the market prices it near zero is buried in two figures. First, despite $40.0M of net income, diluted EPS is -$0.34 — the gap tells you a preferred/participating security stack sits ahead of the common and absorbs the earnings, so GAAP 'profit' does not accrue to the shares you'd buy. Second, operating cash flow was -$25.3M and worsening (-38%), the structural eHealth problem: revenue is booked as the estimated lifetime value of commissions (commissions receivable), but cash arrives over years, so an 'operating-profitable' year still bleeds cash. To fund that gap the company levered up — long-term debt rose 65% to $113M and it opened a new $125M asset-backed revolver with CCP Agency. Cash of $73.7M (+88%) and a modest 0.49x liabilities/equity keep this out of distress, but the combination of negative cash conversion, rising debt and a preferred overhang is exactly why the equity trades at a fraction of book.